Stocks and Investing
Stocks and Investing
Wed, April 26, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mani Foroohar Maintained (ALVR) at Buy with Increased Target to $19 on, Apr 26th, 2023
Mani Foroohar of SVB Securities, Maintained "AlloVir, Inc." (ALVR) at Buy with Increased Target from $16 to $19 on, Apr 26th, 2023.
Mani has made no other calls on ALVR in the last 4 months.
There is 1 other peer that has a rating on ALVR. Out of the 1 peers that are also analyzing ALVR, 0 agree with Mani's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mani
- Michael Ulz of "Morgan Stanley" Maintained at Buy with Decreased Target to $20 on, Friday, January 27th, 2023
Contributing Sources